Author:
Cheng Xin,Chen Zimin,Gao Chen,Zhang Yi,Yang Liuyang,Wan Jiqing,Wei Yujie,Zeng Sheng,Zhang Yiwen,Zhang Yueyue,Li Yuhang,Zhang Weijun,Zou Quanming,Lu Guangwen,Gu Jiang
Funder
Natural Science Foundation of Chongqing Municipality
National Natural Science Foundation of China
Sichuan University
Subject
Molecular Biology,General Medicine,Biochemistry,Structural Biology
Reference35 articles.
1. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update;Reynolds;Drugs,2021
2. Pseudomonas aeruginosa device associated – healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study;Litwin;BMC Infect Dis,2021
3. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies;Pang;Biotechnol. Adv.,2019
4. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics;Qin;Signal Transduct. Target. Ther.,2022
5. Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia;Damron;Microbiology (Reading, England),2009